We are live on ! Find out more
PFM

PacWest Financial Management Portfolio holdings

AUM $169M
1-Year Est. Return 8.84%
This Fund
S&P 500
This Quarter Est. Return
+11.8%
1 Year Est. Return
+8.84%
3 Year Est. Return
+19.16%
5 Year Est. Return
10 Year Est. Return
AUM
$332M
AUM Growth
+$216M
Cap. Flow
+$5.59M
Cap. Flow %
1.68%
Top 10 Hldgs %
71.19%
Holding
97
New
6
Increased
28
Reduced
52
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 65.05%
2 Miscellaneous 10%
3 Technology 5.89%
4 Financials 4.13%
5 Consumer Discretionary 3.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AZN icon
1
AstraZeneca
AZN
$254B
$202M 60.81%
+3,400
New +$185K
IJR icon
2
iShares Core S&P Small-Cap ETF
IJR
$107B
$5.42M 1.63%
99,250
+13,604
+16% +$711K
BSJE
3
DELISTED
GUGGENGEIM BULLETSHARES 2014 HIGH YIELD CORPORATE BOND ETF
BSJE
$4.2M 1.26%
157,402
+63,692
+68% +$1.7M
SPSB icon
4
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$11.3B
$4.16M 1.25%
135,556
-1,189
-0.9% -$36.6K
MSFT icon
5
Microsoft
MSFT
$3.75T
$3.9M 1.18%
104,329
-2,977
-3% -$108K
BSJF
6
DELISTED
GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF
BSJF
$3.7M 1.11%
138,012
+87,297
+172% +$2.35M
VCSH icon
7
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.4B
$3.67M 1.11%
46,023
-600
-1% -$48K
IBM icon
8
IBM
IBM
$235B
$3.27M 0.98%
18,208
-332
-2% -$57.3K
VFC icon
9
VF Corp
VFC
$5.18B
$3.15M 0.95%
53,750
-807
-1% -$42.1K
VCIT icon
10
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$68.7B
$2.99M 0.9%
36,112
-7,259
-17% -$608K
TJX icon
11
TJX Companies
TJX
$139B
$2.9M 0.87%
91,018
+5,120
+6% +$155K
USB icon
12
US Bancorp
USB
$97.9B
$2.63M 0.79%
65,196
+630
+1% +$24.2K
GE icon
13
GE Aerospace
GE
$329B
$2.52M 0.76%
18,761
+1,038
+6% +$131K
BRK.B icon
14
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.48M 0.75%
20,954
-521
-2% -$60.2K
QCOM icon
15
Qualcomm
QCOM
$192B
$2.48M 0.75%
33,336
+65
+0.2% +$4.58K
JNJ icon
16
Johnson & Johnson
JNJ
$642B
$2.29M 0.69%
25,007
-300
-1% -$27.6K
INTC icon
17
Intel
INTC
$514B
$2.24M 0.67%
86,317
-2,460
-3% -$59.5K
XOM icon
18
ExxonMobil
XOM
$679B
$2.19M 0.66%
21,593
-40
-0.2% -$3.7K
RTX icon
19
RTX Corp
RTX
$263B
$2.17M 0.65%
30,224
-88
-0.3% -$6K
CVX icon
20
Chevron
CVX
$416B
$2.15M 0.65%
17,208
+375
+2% +$45.3K
MMM icon
21
3M
MMM
$83.6B
$2.02M 0.61%
17,179
+74
+0.4% +$7.88K
MCD icon
22
McDonald's
MCD
$182B
$1.99M 0.6%
20,463
-590
-3% -$56.7K
VWO icon
23
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$1.98M 0.6%
48,131
-1,435
-3% -$59.2K
CHD icon
24
Church & Dwight Co
CHD
$22.3B
$1.96M 0.59%
59,124
-470
-0.8% -$15.1K
SLB icon
25
SLB Ltd
SLB
$79.1B
$1.95M 0.59%
21,615
+455
+2% +$41.1K

Similar funds

PacWest Financial Management's Q4 2013 Portfolio in Review

As of Q4 2013, PacWest Financial Management held 97 positions worth $332M, up 187% from $116M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

PacWest Financial Management's Q4 2013 filing shows 6 new, 28 increased, 52 reduced and 6 closed positions. Its largest new stake was Bausch Health: 10,575 shares worth $1.24M. The largest sale was CBRE Group, an estimated $904K.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 10% a quarter earlier, followed by Miscellaneous and Technology.

  • PacWest Financial Management's largest Q4 2013 buy was Bausch Health: 10,575 shares worth $1.24M.
  • PacWest Financial Management added most to GUGGENGEIM BULLETSHARES 2015 HIGH YIELD CORPORATE BOND ETF in Q4 2013, an estimated $2.35M increase.
  • PacWest Financial Management's biggest Q4 2013 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $608K.
  • PacWest Financial Management fully exited CBRE Group in Q4 2013, selling an estimated $904K.
  • PacWest Financial Management's ten largest holdings make up 71% of its $332M portfolio in Q4 2013.
  • PacWest Financial Management opened 6 new positions and closed 6 in Q4 2013.
  • PacWest Financial Management's portfolio value rose 187% quarter-over-quarter to $332M.

Based on PacWest Financial Management's 13F filing for Q4 2013, filed 21 Jan 2014.